They are amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (“CDMO”) industry in India in terms of revenue. Incorporated in 2001, Windlas is engaged in formulations CDMO. Contract Development Manufacturing is the emerging area within pharma industry. It entails contract manufacture and research on behalf of large companies.

These are dedicated outsourcing units driven by R&D. Globally, this is a high growth business and India has been making rapid inroads. Windlas has a premium client list its contract manufacturing and research outsourcing. Its client roster includes marquee names like Pfizer, Sanofi India, Intas Pharma and Systopic Laboratories. Windlas also has an exports division which caters exclusively to global clients.

Its manufacturing facilities are located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.

Object of the offer:

The company proposes to utilise the net proceeds from the issue for
• Purchase of equipment required for capacity expansion of existing facility at Dehradun Plant
• To meet working capital requirements
• Repaying of certain borrowings

Company Financials:



Windlas Biotech IPO Details:



Windlas Biotech IPO Tentative Timetable:

The Windlas Biotech IPO open date is Aug 4, 2021, and the close date is Aug 6, 2021. The issue may list on Aug 17, 2021.



Windlas Biotech IPO Lot Size:

The Windlas Biotech IPO market lot size is 30 shares. A retail-individual investor can apply for up to 14 lots (420 shares or ₹193,200 at cut off).

Windlas Biotech IPO Promoter Holding:

• Pre-Issue Share Holding = 78%
• Post-Issue Share Holding = 65.16%

How to apply for IPO?

1. ASBA - All you have to do is, know if your demat is with NSDL or CDSL. Make a note of your Demat ID/DP ID/BO ID - 16 digit number from your broker terminal. Once you have these 2 information, go ahead and apply from your internet banking. One advantage in this process is that, once you submit the application, process ends there and amount gets blocked. While in UPI, you need to get mandate from your bank and need to authorize on time. Many parties are involved in UPI process (Bank, broker, 3rd party UPI app provider etc) and there are chances of delayed UPI mandates. This is a recent process and will take time to settle. Till then, it is better to apply from net banking, but ensure you enter correct 16 digit DP ID.

List of banks that support ASBA. https://www.bsesme.com/static/getlis...x?expandable=0

2. UPI - Visit your broker terminal, select the IPO, enter UPI ID and other bid details to submit the application. Wait for mandate to arrive on UPI app. Approve the mandate to block the amount.

Refer to this video to apply for IPO using UPI at Zerodha.